Project company

The project company Xsight Optics successfully participates in the start-up competition ? the prize money funds a relevant R&D project


Xsight Optics, based in Jena (Germany), a project company of Xlife Sciences AG (SIX: XLS), has successfully participated in this year’s StartUp contest ?get started 2gether? organized by the Thuringian Research and Technology Association and the Thuringian Ministry of Economics: the company won funding for a relevant new research and development project and also received the audience award.

Xsight Optics’ vision is to expand human-centered digital care. To this end, the company is developing a wearable optical sensor with which medical staff in hospitals and care facilities can, for example, record the heart rate, oxygen saturation, temperature and respiratory rate of patients from a safe distance. without contact (and transfer directly into an already existing documentation system).

This mobile sensor derives these health parameters from multiple image properties through an intelligent combination of optical technology, microelectronics, and AI-supported algorithms. At the heart of this is secure and reliable imaging software. The awarded prize of 80,000 euros will allow Xsight Optis to finance a corresponding R&D project with the Department of Intelligent Systems of the Institute for Applied Building Research in Weimar.

Oliver R. Baumann, CEO of Xlife Sciences, comments: “We warmly congratulate CEO Maria Nisser and CSO Jan Sperrhake of our project company Xsight Optics for their doubly successful presentation at the famous Thuringian StartUp funding award “get started 2gether”. . The funding thus obtained for the interdisciplinary research and development project with computer vision and data analysis experts from the Institute for Applied Building Research in Weimar is an important step for Xsight Optics’ efforts to expand the human-centered digital care.

Financial calendar

Ordinary General Meeting 2022 June 20, 2022

2022 half-year results September 28, 2022


Information for journalists: IRF Reputation AG, Valentin Handschin, [email protected]

Investor information: Xlife Sciences AG, Dennis Lennartz, [email protected]

Source link